(HealthDay)— A drug regimen containing two powerful antifungal medicines—amphotericin B and flucytosine—reduced the risk of dying from cryptococcal meningitis by 40 percent compared to treatment with amphotericin B ...
Apr 3, 2013
1
0
The European Centre for Disease Control has today announced it is examining current evidence for the possible environmental origin of drug resistance in a group of diseases known as Aspergillus infection, following Manchester ...
Mar 1, 2013
0
0
A pair of commentaries to appear in an upcoming issue of the journal Antimicrobial Agents and Chemotherapy highlight a debate within the public health community surrounding Centers for Disease Control and Prevention (CDC) ...
Feb 5, 2013
1
0
Neutron scattering experiments have provided new insights into the origin of the side effects of an antifungal drug prescribed all over the world. The analysis conducted by scientists at King's College London and the Institut ...
Oct 29, 2012
0
0
(AP)—Vilinda York lies in her Florida hospital bed, facing a dry-erase board that lists in green marker her name, her four doctors and a smiley face.
Oct 20, 2012
1
0
In a new perspective piece being published Online First tonight in Annals of Internal Medicine, a physician recalls lessons learned from treating patients affected by the 2002 outbreak of Exophiala (Wangiella) dermatitidis ...
Oct 18, 2012
0
0
A new study published in the British Journal of Clinical Pharmacology provides insights on how common hospitalized patients develop liver injury from taking different medications.
May 5, 2021
0
3
New research published in the British Journal of Pharmacology indicates that two currently available medications—an antifungal drug and an antidepressant—can effectively inhibit the virus that causes COVID-19 in laboratory ...
Apr 7, 2021
0
9
New chemical compounds that suppress viruses and fungi were synthesized by scientists from South Ural State University and the Institute of Organic Chemistry Russian Academy of Sciences, together with an international team ...
Jan 29, 2021
0
3
Drugmaker Pfizer says it's received the final regulatory approvals for its $15.23 billion purchase of the injectable drug and infusion device maker Hospira, and says the deal will close in early September.
Aug 24, 2015
0
10
